4arthritisinfo.co.uk Rotating Header Image

Chugai Defends Actemra Arthritis Drug After Report on Deaths (Bloomberg)

March 18 (Bloomberg) — Chugai Pharmaceutical Co. defended its Actemra arthritis drug after a report linking the medication to deaths sent the stock plunging the most this year.

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Propeller
  • StumbleUpon
  • Technorati
  • TwitThis

Comments are closed.